Jonas Webb Building
9 articles with Cambridge Epigenetix
Biopharma and life sciences organizations from across the globe provide updates on their pipelines and businesses.
Cambridge Epigenetix announces programme for routine screening and detection of colorectal cancer and other common tumours
Company granted broad and exclusive patent rights for the use of an epigenetic biomarker as a diagnostic tool for cancer.
Eight so-called “superstar scientists” based in Cambridge, UK, have co-founded an investment fund dubbed Ahren with 100 million pounds, so far. One of their first investments is in biotech company Cambridge Epigenetix for $10 million.
The appointment further strengthens CEGX's panel of opinion leaders providing expert advice across the Company's key focus areas of epigenetics, oncology, liquid biopsy, diagnostic and therapeutic development.
Cambridge Epigenetix And NuGEN Sign Partnership Agreement To Combine Leading Technologies In Epigenetics Research